PICC dressings: Not just a decision based upon clinical performance

JAVA - Journal of the Association for Vascular Access

Volumn 8, Issue 4, 2003, Pages 41-43

  Gabriel, Janice ^a,b,c  

^a ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ROYAL COLLEGE OF NURSING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BANDAGE; CATHETER INFECTION; CHEMOTHERAPY; CLINICAL PRACTICE; CYSTIC FIBROSIS; DEVICE; DEVICE INFECTION; HUMAN; INFECTION RISK; INTRAVENOUS CATHETER; MEDICAL DECISION MAKING; PATIENT SATISFACTION; PHLEBITIS; PROTECTIVE CLOTHING; RISK ASSESSMENT; VASCULAR ACCESS; VEIN CATHETERIZATION;

EID: 4644222881     PISSN: 10830081     EISSN: None     Source Type: Journal    
DOI: 10.2309/155288503774651760     Document Type: Article

References (17)

1. Gabriel J. Long-Term central venous access. IN Dougherty L & Lamb J (eds) Intravenous Therapy in Nursing Practice. Churchill Livingstone: London, 1999.
2. Gabriel J. What patients think of a PICC. JVAD 2000; 5(4): 26-29.
3. Nugent K, Chernecky C, Macklin D. 2002 Using focus groups to evaluate patient involvement in decision-making associated with their vascular access device. JVAD 2002; 7(2): 33-37.
4. Lawson M, Kavanagh T. McCredie K, et al. Comparison of transparent dressing to paper tape dressing over central venous catheter sites. NITA 1991; 9: 40-44.
5. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trail of povidone-iodine, alcohol and chlorhexidine for prevention of infection with central venous and arterial catheters: LANCET 1991;: 338: 339-343.
6. Goodwin M, Carlson I. The Peripherally Inserted Central Catheter: A retrospective look at three years of insertions. J Intraven Nurs 1993; 16(2): 92-103.
7. Hadaway L. An Overview of vascular access devices inserted via the antecubital area. J Intraven Nurs 1989; 13(5): 297-306.
8. Gabriel J. PICC securement: minimising potential complications: Nurs Standard 2001; 15(43): 42-44
9. Stacey W. Teddy Holds Fast: Poster presentation NAVAN Conference 2000, San Diego, CA: Sept 2000.
10. Crnich CJ, Maki D. The Promise of Novel Technology for the prevention of intravascular device-related bloodstream Infection. II. Long-term devices. Healthcare Epidemiol CID 2002; 34: (10): 1362-1368.
11. Maki DG, Stolz SS, Wheeler S, Mermel L. A prospective, randomised trail of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management. Critical Care Med 1994; 22(11): 1729-1737.
12. Fitchie C. Central venous catheter-related infection and dressing type. Intensive Critical Care Nurs 1992; 8: 199-202.
13. Treston-Aurand J, Olmstead R, Allen-Bridson K, Craig CP. Impact of dressing materials on central venous catheter infection rates. J Intraven Nurs 1997; 20(4): 201-206.
14. Banton J, Banning V. Impact on catheter-related bloodstream infections with the use of the Biopatch dressing. JVAD 2002; 7(3): 27-32.
15. Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 2001; 7(2): 197-199.
16. Young GP, Alexeyeff M, Russell, DM, Thomas RJ. Catheter sepsis during parenteral nutrition: the safety of long-term OpSite dressings. JPEN 1988; 12(4): 365-370.
17. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the preventions of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 21(12): 759-769.